In This Article:
NEW YORK, NY / ACCESSWIRE / January 24, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
NERV Shareholders Click Here: https://www.zlk.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=12382&wire=1
SWI Shareholders Click Here: https://www.zlk.com/pslra-1/solarwinds-corporation-information-request-form?prid=12382&wire=1
QSR Shareholders Click Here: https://www.zlk.com/pslra-1/restaurant-brands-international-inc-loss-submission-form?prid=12382&wire=1
* ADDITIONAL INFORMATION BELOW *
Minerva Neurosciences, Inc. (NASDAQ: NERV)
NERV Lawsuit on behalf of: investors who purchased May 15, 2017 - November 30, 2020
Lead Plaintiff Deadline : February 8, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=12382&wire=1
According to the filed complaint, during the class period, Minerva Neurosciences, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the truth about the feedback received from the FDA concerning the "end-of-Phase 2" meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company's plan to use the combination of the Phase 2b and Phase 3 studies would be "highly unlikely" to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to "substantial review issues" because the trials were inadequate and not well-controlled; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.
SolarWinds Corporation (NYSE: SWI)
SWI Lawsuit on behalf of: investors who purchased February 24, 2020 - December 15, 2020
Lead Plaintiff Deadline : March 5, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/solarwinds-corporation-information-request-form?prid=12382&wire=1
According to the filed complaint, during the class period, SolarWinds Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds' update server had an easily accessible password of ‘solarwinds123'; (3) consequently, SolarWinds' customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants' statements about SolarWinds's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.